Per Svedenhag
Verkoop & Marketing bij SCIBASE HOLDING AB (PUBL)
Oorsprong van het eerstegraads netwerk van Per Svedenhag
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Medical Specialties | 23 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Per Svedenhag via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| Scibase AB | Director/Board Member Chairman Corporate Officer/Principal Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member | ||
| Scibase Intressenter AB | Director/Board Member Corporate Officer/Principal Chairman Chief Executive Officer Director/Board Member | ||
| AEROCRINE AB | Electronic Equipment/Instruments | Director/Board Member Director of Finance/CFO Sales & Marketing | |
University of Linköping
 University of Linköping Other Consumer ServicesConsumer Services Linköping University Hospital provides healthcare services. | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
| OSSDSIGN AB | Medical Specialties | Director/Board Member Chief Executive Officer Director/Board Member | |
Neoventa Medical AB
 Neoventa Medical AB Medical SpecialtiesHealth Technology Neoventa Medical AB develops and markets monitoring and management tools for neonatal healthcare. Its products include Stan S31, Stan Viewer Live, Stan Viewer, Stan Method, and Goldtrace. The company was founded in 1997 and is headquartered in Mölndal, Sweden. | Medical Specialties | Chief Executive Officer Director/Board Member Director/Board Member | |
| Stockholm School of Economics | College/University | Masters Business Admin Undergraduate Degree | |
Neoventa Holding AB
 Neoventa Holding AB MiscellaneousMiscellaneous Neoventa Holding AB invests in companies with interests in development and marketing of monitoring and control equipment for perinatal care. The company is headquartered in Molndal, Sweden. | Miscellaneous | Director/Board Member Director/Board Member | |
| INSEAD | College/University | Masters Business Admin Undergraduate Degree | |
| CALLIDITAS THERAPEUTICS AB | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| Karolinska Institutet | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
SEB Venture Capital
 SEB Venture Capital Investment ManagersFinance SEB Venture Capital (SEB Venture Capital) is a venture capital subsidiary of Skandinaviska Enskilda Banken AB founded in 1995. The firm is headquartered in Stockholm, Sweden. | Investment Managers | Corporate Officer/Principal Private Equity Investor | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Chief Executive Officer Chief Investment Officer | |
| PROMIMIC AB | Medical Specialties | Chairman Corporate Officer/Principal | |
ENCare AB
 ENCare AB Packaged SoftwareTechnology Services ENCare AB provides interactive and web-based information system for healthcare industry. It offers an interface for the collection, documentation, and feedback of performance from clinical experts. The company was founded by Olle Harald Ljungqvist and Knut Ivar Magnus Stafsing in 2009 and is headquartered in Stockholm, Sweden. | Packaged Software | Chairman Chairman | |
| BOULE DIAGNOSTICS AB | Medical Specialties | Director/Board Member Director/Board Member | |
Synectics Medical AB
 Synectics Medical AB Information Technology ServicesTechnology Services Part of Medtronic Plc, Synectics Medical AB is a Swedish company that develops computer support systems for the healthcare industry. The company is based in Stockholm, Sweden. The company was founded by Anders Essen-Möller. Synectics Medical was acquired by Medtronic, Inc., part of Medtronic Plc from January 27, 2015 on March 11, 1996 for $59 million. | Information Technology Services | Chief Executive Officer Corporate Officer/Principal | |
| INDEX PHARMACEUTICALS HOLDING AB | Pharmaceuticals: Major | Chairman Director/Board Member | |
Karolinska Development AB (Private Equity)
 Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | Investment Managers | Chief Executive Officer Director of Finance/CFO | |
| VITROLIFE AB | Medical Specialties | Chairman Chairman | |
| GHP SPECIALTY CARE AB (PUBL) | Medical/Nursing Services | Chairman Chairman | |
| University of Gothenburg | College/University | Graduate Degree Masters Business Admin | |
Fairpoint Capital AB
 Fairpoint Capital AB Investment ManagersFinance Fairpoint Capital AB (Fairpoint Capital) is a venture capital firm founded in 2018. The firm is headquartered in Stockholm, Sweden. | Investment Managers | Director of Finance/CFO | |
| NEWRON PHARMACEUTICALS S.P.A. | Pharmaceuticals: Major | Director/Board Member | |
| Technical University of Berlin | College/University | Doctorate Degree | |
ImCyse SA
 ImCyse SA BiotechnologyHealth Technology ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium. | Biotechnology | Chairman | |
| Bluehaven Therapeutics AG | Chief Executive Officer | ||
| INFLARX N.V. | Biotechnology | Director of Finance/CFO | |
Memo Therapeutics AG
 Memo Therapeutics AG BiotechnologyHealth Technology Memo Therapeutics AG develops recombinant immunoglobulins and human-derived monoclonal antibodies. Its products include human antibodies, human immune repertoire analysis, classic antibody discovery and pipeline. The company was founded by Christoph Esslinger on November 29, 2012 and is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member | |
Pharmacia & Upjohn Co. LLC
 Pharmacia & Upjohn Co. LLC Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pharmacia & Upjohn Co. LLC is a company that manufactures and supplies pharmaceutical goods. The company is based in Bingham Farms, MI. | Pharmaceuticals: Major | Comptroller/Controller/Auditor | |
| University of Uppsala | College/University | Masters Business Admin | |
Pulmagen Therapeutics (Synergy) Ltd.
 Pulmagen Therapeutics (Synergy) Ltd. Miscellaneous Commercial ServicesCommercial Services Pulmagen Therapeutics (Synergy) Ltd. develops therapeutics for respiratory diseases. It engages in developing various internal proprietary programs in chronic obstructive pulmonary disease, asthma, and cystic fibrosis. The company was founded in August 2000 and is headquartered in Stevenage, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
| SENZIME AB | Medical Specialties | Chief Executive Officer | |
| MEDIGENE AG | Biotechnology | Chief Executive Officer | |
Sophion Bioscience A/S
 Sophion Bioscience A/S Medical SpecialtiesHealth Technology Sophion Bioscience A/S develops, manufactures and markets instruments and supplies automated patch clamping. It develops throughput patch clamp solutions for functional characterization of living cells. The firm products are used in pharmaceutical and biotech companies around the world. The company was founded in July 2007 and is headquartered in Ballerup, Denmark. | Medical Specialties | Director/Board Member | |
Egalet Ltd.
 Egalet Ltd. Pharmaceuticals: MajorHealth Technology Egalet Ltd. engages in manufacturing of basic pharmaceutical products. It focuses on the commercialization and development of abuse resistant formulations of opioids and other pain care drugs. The company was founded on July 15, 2010 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
SpineVision SA
 SpineVision SA Medical SpecialtiesHealth Technology SpineVision SA develops and markets implants for the treatment of spinal disorders. It also designs instrumentation for the spinal treatments. Its products include Flex 2, Lumis, Plus/X-Plus, ULIS, Unithread, Spacevisions, and C3. The firm also offers solutions for spinal pathologies, such as lumbar degenerative disc diseases, deformities, cervical disorders, trauma, and tumors. The company was founded by Gérard Vanacker on July 16, 1999 and is headquartered in Antony, France. | Medical Specialties | Director/Board Member | |
| ZYLA LIFE SCIENCES | Pharmaceuticals: Major | Director/Board Member | |
Egalet A/S
 Egalet A/S Pharmaceuticals: MajorHealth Technology Egalet A/S operates as a specialty pharmaceuticals company. It develops opioid formulations for pain management based on abuse deterrent prolonged release erosion matrix technology in Denmark. The company develops prolonged and delayed release therapeutics for chronic pain management, including Parvulet, a delivery platform for facilitating dispensing of oral doses to pediatric and geriatric patient segments; and Egalet morphine. The company was founded by Jan Quistgaard in 1995 and is headquartered in Vaerloese, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
Danish BioVenture General Partner ApS
 Danish BioVenture General Partner ApS Financial ConglomeratesFinance Danish BioVenture General Partner ApS operates as a general partner and renders investment advice to K/S Danish BioVenture. It manages the administration and acts as a representative of Danish BioVenture in external commercial relations. The company was founded on June 26, 2009 and is headquartered in Copenhagen, Denmark. | Financial Conglomerates | Director/Board Member | |
4sigma GmbH
 4sigma GmbH Miscellaneous Commercial ServicesCommercial Services Part of 4Sigma Luxembourg SARL, 4sigma GmbH operates a hotline that provides medical advice to patients. The company is based in Oberhaching, Germany. The CEO of the German company is Horst-Günter Bohnenkamp. | Miscellaneous Commercial Services | Director/Board Member | |
MedSkin Solutions Dr. Suwelack AG
 MedSkin Solutions Dr. Suwelack AG Household/Personal CareConsumer Non-Durables MedSkin Solutions Dr. Suwelack AG engages in research to utilize biological modes of action for use in medical care, aesthetic care and professional skin care. The firm offers MatriDerm and ProHeal products. The firm offers solution's for med and advanced wound care, tissue regeneration and haemostasis. The company was founded in 1997 and is headquartered in Billerbeck, Germany. | Household/Personal Care | Chief Executive Officer | |
| Humboldt-Universität zu Berlin | College/University | Masters Business Admin | |
| 3I GROUP PLC | Investment Managers | Corporate Officer/Principal |
Statistieken
Internationaal
| Zweden | 25 |
| Duitsland | 8 |
| Verenigd Koninkrijk | 7 |
| Denemarken | 5 |
| Verenigde Staten | 4 |
Sectoraal
| Health Technology | 22 |
| Consumer Services | 9 |
| Finance | 9 |
| Commercial Services | 5 |
| Technology Services | 3 |
Operationeel
| Director/Board Member | 161 |
| Chairman | 63 |
| Corporate Officer/Principal | 51 |
| Independent Dir/Board Member | 34 |
| Chief Executive Officer | 28 |
Sterkste connecties
- Beurs
- Insiders
- Per Svedenhag
- Bedrijfsconnecties
